Abstract

Simple SummaryTreatment abandonment is a leading cause of mortality for children with retinoblastoma worldwide. Noncompliance is influenced by both clinical and social factors including parents’ lack of appreciation of the aggressive nature of the disease. The natural history of retinoblastoma has not been previously studied because it is unethical to subject children with active cancer to nonintervention, and children who abandoned treatment were often lost to follow-up. Through phone interviews with families of children who abandoned treatment, we deduced the timeline of uninterrupted retinoblastoma disease progression. We showed that intraocular retinoblastoma progress to orbital extension had a median period of 13.7 months, from orbital disease to systemic metastasis 2.6 months and with only 2.0 months to death. If left untreated, 100% of children died within 48 months from diagnosis. We hope these new findings encourage clinicians and parents to make informed decisions in the management of children with retinoblastoma.Treatment abandonment is a leading cause of death in children with retinoblastoma worldwide. We studied children who abandoned treatment upfront at diagnosis to delineate the natural history of untreated retinoblastoma. Studied were children who received no treatment, diagnosed between 2007 and 2017 at 29 Chinese centers. Data were retrospectively collected from medical chart reviews and interviews with each patient’s family. During the study period, 44 children received no treatment after diagnosis of retinoblastoma. Clinical or radiologic evidence of orbital extension was available for 25 children, and radiologic evidence of systemic metastasis was available for 12 children. Median times from diagnosis of intraocular tumor to orbital disease was 13.7 months, orbital disease to metastasis was 2.6 months, and metastasis to death was 2.0 months. Children with brain metastasis had shorter survival than those with metastasis to other sites (median 1.0 vs. 3.1 months; p = 0.015). Overall, 36% of patients died within 12 months of diagnosis, 77% within 24 months, 95% within 36 months and 100% within 48 months. While multiple factors influence refusal of treatment, insights into the natural history of retinoblastoma derived from real-world evidence can inform clinicians and parents that retinoblastoma is life-threatening and encourage urgent treatment at diagnosis.

Highlights

  • Retinoblastoma, the most common pediatric intraocular malignancy [1], is one of the most curable cancers, especially with early diagnosis

  • Despite good survival and globe prognosis with these therapies, noncompliance is a major cause of death in low- and middle- income countries, where the majority of patients with retinoblastoma reside [14]

  • A large retrospective study by Vasquez, L. et al shows that children diagnosed with retinoblastoma were at a higher risk of treatment abandonment compared to those diagnosed with all other pediatric solid tumors [17]

Read more

Summary

Introduction

Retinoblastoma, the most common pediatric intraocular malignancy [1], is one of the most curable cancers, especially with early diagnosis. Despite good survival and globe prognosis with these therapies, noncompliance is a major cause of death in low- and middle- income countries, where the majority of patients with retinoblastoma reside [14]. Treatment refusal and abandonment in childhood cancer is a complex multifactorial phenomenon influenced by both socio and disease-specific factors. Enucleation of eyes with retinoblastoma is a life-saving procedure readily available in most settings, the stigma associated with eye removal too often leads parents to refuse or abandon therapy. A large retrospective study by Vasquez, L. et al shows that children diagnosed with retinoblastoma were at a higher risk of treatment abandonment compared to those diagnosed with all other pediatric solid tumors [17].

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.